Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India

• Main Authors: Sharad Agarkhedkar (Author), Jugesh Chhatwal (Author), Rajeev Zachariah Kompithra (Author), Sanjay K. Lalwani (Author), Arun Narayan (Author), Vinay Muninarayanaswam (Author), Nithya Gogtay (Author), Kristin Dotter (Author), Viviane Gresset-Bourgeois (Author)
• Format: Book
• Published: Taylor & Francis Group, 2019-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

A quadrivalent split-virion inactivated influenza vaccine (IIV4; Fluzone® Quadrivalent, Sanofi Pasteur) has been available in the US since 2013 for individuals aged ≥ 6 months. Here, we describe the results of an open-label, multicenter trial (WHO Universal Trial Number U1111-1143-8370) evaluating t...